SCHEMBL4884225

SCHEMBL4884225

O=C(c1nc2ccc(O)cc2[nH]1)N1CCC(=Cc2ccc(F)cc2)CC1

nearest known ligand 0.63

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 6/20 0.55
HRH3 Q9Y5N1 2/20 0.47
ALOX15 P16050 1/20 0.43
PDE10A Q9Y233 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4888577 0.90 HRH4 (0.56) HRH4HRH3ALOX15
SCHEMBL4891849 0.90 HRH4 (0.55) HRH4HRH3ALOX15
SCHEMBL4888727 0.89 HRH4 (0.47) HRH4HRH3ALOX15
SCHEMBL4884675 0.87 DRD3 (0.47) HRH4HRH3ALOX15
SCHEMBL4884330 0.70 HRH4 (0.60) HRH4HRH3
SCHEMBL19994676 0.69 SRD5A2 (0.48)
SCHEMBL4814999 0.67 GRIN1 (0.67)
SCHEMBL4812905 0.66 GRIN1 (0.66)
SCHEMBL602139 0.66 HRH4 (0.60) HRH4HRH3
SCHEMBL4806542 0.66 PIN1 (0.68)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080300276-A1 Heterocyclic Carboxylic Acide Amide Derivatives RICHTER GEDEON VEGYESZETI GYAR RT. (HU) 2008-12-04 US claimed
EP-1771437-A1 NEW HETEROCYCLIC CARBOXYLIC ACID AMIDE DERIVATIVES RICHTER GEDEON VEGYESZETI GYAR R.T. (HU) 2007-04-11 EP claimed
WO-2006010969-A1 NEW HETEROCYCLIC CARBOXYLIC ACID AMIDE DERIVATIVES Richter Gedeon Vegyészeti Gyár Rt. (HU) 2006-02-02 WO claimed
US-20080300276-A1 Heterocyclic Carboxylic Acide Amide Derivatives RICHTER GEDEON VEGYESZETI GYAR RT. (HU) 2008-12-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080300276-A1 Heterocyclic Carboxylic Acide Amide Derivatives HCAR2, GRIN1, HCAR1 HRH4 16/4885HRH3 39/4885ALOX15 1151/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.